ticrynafen has been researched along with Autoimmune Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergue, A; Eugène, C; Patriarche, C; Quevauvilliers, J | 1 |
Homberg, JC | 1 |
André, C; Beaune, PH; Lecoeur, S | 1 |
Beaune, PH; Belloc, C; Gauffre, A; Gautier, JC; Lecoeur, S | 1 |
1 review(s) available for ticrynafen and Autoimmune Disease
Article | Year |
---|---|
[Autoimmunity induced by drugs. Immunological characteristics and etiopathogenic hypotheses].
Topics: Animals; Autoimmune Diseases; Cardiac Glycosides; Chemical and Drug Induced Liver Injury; Drug Combinations; Humans; Iproniazid; Lymphocytes; Methimazole; Methyldopa; Penicillamine; Plant Extracts; Pyrazoles; T-Lymphocytes; Ticrynafen | 1984 |
3 other study(ies) available for ticrynafen and Autoimmune Disease
Article | Year |
---|---|
[Tienilic acid as a likely cause of "auto immune" active hepatitis (author's transl)].
Topics: Aged; Anthraquinones; Autoimmune Diseases; Cathartics; Chemical and Drug Induced Liver Injury; Dioctyl Sulfosuccinic Acid; Drug Therapy, Combination; Female; Glycolates; Humans; Liver; Male; Middle Aged; Ticrynafen; Transaminases | 1980 |
Tienilic acid-induced autoimmune hepatitis: anti-liver and-kidney microsomal type 2 autoantibodies recognize a three-site conformational epitope on cytochrome P4502C9.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Autoantibodies; Autoimmune Diseases; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Epitope Mapping; Humans; Infant; Rabbits; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Ticrynafen | 1996 |
Use of heterologous expression systems to study autoimmune drug-induced hepatitis.
Topics: Autoantibodies; Autoimmune Diseases; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Escherichia coli; Gene Expression; Humans; In Vitro Techniques; Models, Biological; Recombinant Proteins; Saccharomyces cerevisiae; Ticrynafen | 1996 |